PLASMA FIBROBLASTIC GROWTH FACTOR 23 LEVELS AS PROGNOSTIC BIOMARKER IN CRITICALLY ILL PATIENTS

Please use this identifier to cite or link to this item: https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6036

Full metadata record

DC Field	Value	Language
dc.contributor.author	ROOPASHREE A.	-
dc.date.accessioned	2026-02-26T05:56:00Z	-
dc.date.available	2026-02-26T05:56:00Z	-
dc.date.issued	2020	-
dc.identifier.uri	https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6036	-
dc.description.abstract	It is considered that prognostication is one of the most electrolyte important aspect of critical care. Many parameters and scoring scales have been studied and followed in this aspect. FGF-23 is a recently found FGF and functions as an endocrine hormone that regulates phosphorus homeostasis. It has been linked to predict mortality in CKD and AKI and also recently in all critical patients. So we have undertaken this study to evaluate the role of FGF 23 as a prognostic marker in critically ill patients	en_US
dc.language.iso	en	en_US
dc.publisher	BLDE (DU)	en_US
dc.subject	Fibroblast growth factor 23, FGF 23, APACHE II Score.	en_US
dc.title	PLASMA FIBROBLASTIC GROWTH FACTOR 23 LEVELS AS PROGNOSTIC BIOMARKER IN CRITICALLY ILL PATIENTS	en_US
dc.type	Other	en_US
Appears in Collections:	Department of General Medicine

Files in This Item:

File	Description	Size	Format
ROOPASHREE A-2020.pdf		2.02 MB	Adobe PDF	View/Open